The invention relates to the technical field of
gene editing, in particular to a gRNA composition of a targeted CYP392E1
gene for preventing and treating
tetranychus urticae and application of the gRNA composition. The CYP392E1
gene of which the
nucleotide sequence is shown as SEQ ID NO.1 and any one of the following applications of gRNA of which the
nucleotide sequence is shown as SEQ ID NO.2: 1) preventing and treating
tetranychus urticae, and / or preparing a
medicine for preventing and treating
tetranychus urticae; and 2) reducing the resistance of the
tetranychus urticae to the
acaricide, and / or preparing a
drug for reducing the resistance of the
tetranychus urticae to the
acaricide. The gRNA is designed by applying a
gene knockout technology, especially aiming at a detoxification
enzyme gene for regulating detoxification
metabolism in a pest
mite body, a compound consisting of the gRNA composition and cas9
protein is delivered into a
tetranychus urticae body by utilizing a
microinjection technology, and the gRNA composition loses the function of a
target gene, reduces the detoxification
metabolism capability of a medicament, and can be used for treating the pest
mite body. The resistance reversion of the two-spotted spider mites is promoted, so that the aim of preventing and treating the two-spotted spider mites is